- Filed
- Mar 12, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Short Term Investments | Q2 2025 · Feb 1, 2025 | $105.9M |
| Short Term Investments | Q2 2025 · Aug 3, 2024 | $84.11M |
| Cash And Equivalents | Q2 2025 · Feb 1, 2025 | $113.21M |
| Cash And Equivalents | Q2 2025 · Aug 3, 2024 | $162.86M |
| Current Liabilities | Q2 2025 · Feb 1, 2025 | $191.15M |
| Current Liabilities | Q2 2025 · Aug 3, 2024 | $203.55M |
| Total Liabilities | Q2 2025 · Feb 1, 2025 | $274.88M |
| Total Liabilities | Q2 2025 · Aug 3, 2024 | $299.84M |
| Current Assets | Q2 2025 · Feb 1, 2025 | $352.9M |
| Current Assets | Q2 2025 · Aug 3, 2024 | $366.71M |
| Total Assets | Q2 2025 · Feb 1, 2025 | $472.64M |
| Total Assets | Q2 2025 · Aug 3, 2024 | $486.86M |
| Shares Diluted | Q2 2025 · Jan 27, 2024 | 119.05M sh |
| Shares Diluted | Q2 2025 · Jan 27, 2024 | 117.85M sh |
| Capex | Q2 2025 · Jan 27, 2024 | $7.43M |
| Stockholders Equity | Q2 2025 · Jan 27, 2024 | $213.27M |
| Stockholders Equity | Q2 2025 · Oct 28, 2023 | $230.74M |
| Stockholders Equity | Q2 2025 · Jul 29, 2023 | $247.31M |
| Eps Diluted | Q2 2025 · Jan 27, 2024 | −$0.30 |
| Eps Diluted | Q2 2025 · Jan 27, 2024 | −$0.60 |
| Eps Basic | Q2 2025 · Jan 27, 2024 | −$0.30 |
| Eps Basic | Q2 2025 · Jan 27, 2024 | −$0.60 |
| Sga Expense | Q2 2025 · Jan 27, 2024 | $181.52M |
| Sga Expense | Q2 2025 · Jan 27, 2024 | $369.28M |
| Net Income | Q2 2025 · Jan 27, 2024 | −$35.52M |
| Net Income | Q2 2025 · Jan 27, 2024 | −$71.01M |
| Operating Income | Q2 2025 · Jan 27, 2024 | −$38.04M |
| Operating Income | Q2 2025 · Jan 27, 2024 | −$66.7M |
| Gross Profit | Q2 2025 · Jan 27, 2024 | $143.48M |
| Gross Profit | Q2 2025 · Jan 27, 2024 | $302.58M |
| Cost Of Revenue | Q2 2025 · Jan 27, 2024 | $186.92M |
| Cost Of Revenue | Q2 2025 · Jan 27, 2024 | $392.6M |
| Revenue | Q2 2025 · Jan 27, 2024 | $330.4M |
| Revenue | Q2 2025 · Jan 27, 2024 | $695.19M |